Sunrest LifescienceNSE:SUNREST 41 PEG Ratio is 0.06 as of Jul. 11, 2026, which is 45% below its 10-year median of 0.11. GuruFocus rates NSE:SUNREST with a GF Score™ of 41/100. The stock has 5 warning signs investors should review. Among 224 Healthcare Providers & Services companies, Sunrest Lifescience ranks better than 99.11% on this metric.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Sunrest Lifescience's PEG Ratio or its related term are showing as below:
NSE:SUNREST'
s PEG Ratio Range Over the Past 10 Years
Min: 0.04 Med: 0.11 Max: 0.13
Current: 0.06
During the past 7 years, Sunrest Lifescience's highest PEG Ratio was 0.13. The lowest was 0.04. And the median was 0.11.
NSE:SUNREST's PEG Ratio is ranked better than 99.11% of 224
companies
in the Healthcare Providers & Services industry
Industry Median: 1.385
vs NSE:SUNREST: 0.06
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Sunrest Lifescience (NSE:SUNREST) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Sunrest Lifescience PEG Ratio Related Terms
Sunrest Lifescience PEG Ratio Historical Data
* Premium members only.
The historical data trend for Sunrest Lifescience's PEG Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sunrest Lifescience PEG Ratio Competitor Comparison
For the Pharmaceutical Retailers subindustry, Sunrest Lifescience's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sunrest Lifescience PEG Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Sunrest Lifescience's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Sunrest Lifescience's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Sunrest Lifescience (NSE:SUNREST) has a PEG Ratio of 0.06 as of Jul. 11, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Sunrest Lifescience and its competitors. This is 45% below median its historical median of 0.11. Over the past decade, Sunrest Lifescience's PEG Ratio has ranged from 0.04 to 0.13. According to the industry distribution chart, Sunrest Lifescience ranks #2 out of 224 companies in the Healthcare Providers & Services industry, placing it in the top 0.90000000000001%.
Is Sunrest Lifescience's PEG Ratio too high?
Sunrest Lifescience's current PEG Ratio of 0.06 is 45% below median its 10-year median of 0.11. Over the past 10 years, this metric has ranged from a low of 0.04 to a high of 0.13. The Healthcare Providers & Services industry median PEG Ratio is 1.39. Sunrest Lifescience's value of 0.06 is 95.7% below this industry median. Based on the distribution chart, Sunrest Lifescience ranks #2 out of 224 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Sunrest Lifescience has a GF Score™ of 41/100, reflecting its overall financial health beyond just this single metric.
How does Sunrest Lifescience's PEG Ratio compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Sunrest Lifescience ranks #2 out of 224 companies for PEG Ratio. This places Sunrest Lifescience in the top 1% of its industry — outperforming the majority of peers. The industry median PEG Ratio is 1.39. Sunrest Lifescience's value of 0.06 is 95.7% below this benchmark. Historically, Sunrest Lifescience's own PEG Ratio has ranged from 0.04 to 0.13 over the past decade. While the company's 10-year median is 0.11 vs. the industry median of 1.39, Sunrest Lifescience has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Healthcare Providers & Services company?
The median PEG Ratio among Healthcare Providers & Services companies is 1.39, based on 224 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sunrest Lifescience's current PEG Ratio of 0.06 is 95.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Sunrest Lifescience and its competitors. For the Healthcare Providers & Services industry, the median PEG Ratio is 1.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sunrest Lifescience's current PEG Ratio is 0.06, which is 45% below median its own 10-year median of 0.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sunrest Lifescience stock overvalued right now?
Sunrest Lifescience (NSE:SUNREST) has a current PEG Ratio of 0.06. The current PEG Ratio is 0.06, which is 45% below median its 10-year median of 0.11 and 95.7% below the Healthcare Providers & Services industry median of 1.39. Sunrest Lifescience's overall GF Score™ is 41/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For Sunrest Lifescience (NSE:SUNREST), the current PEG Ratio is 0.06 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Sunrest Lifescience Ltd is engaged in the trading business of pharmaceutical products, including capsules, tablets, syrups, ointments, gels, mouthwash, and toothpaste on a wholesale and retail basis. Its product portfolio covers categories such as anti-bacterial, anti-diarrheal, anti-fungal, anti-malarial, anti-diabetic, dental care, anti-inflammatory, nutraceuticals, and more. The company works with a network of suppliers and super suppliers, distributing products to chemists, hospitals, and dispensaries across multiple Indian states. Sunrest relies on both in-house manufacturing through its group company Trilend Pharmaceuticals and third-party manufacturers, emphasizing quality control and regulatory compliance.
41GF Score
Get the complete analysis for NSE:SUNREST
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:SUNREST has been successfully added to your 
